For Governments
Consent you can audit.
Population health infrastructure, inspectable from consent to approved use.
Configure longitudinal women's health infrastructure around local law, public accountability and interoperable care.
The public infrastructure problem
Longitudinal data needs accountability that survives every exchange.
Population health programs must coordinate across institutions without turning consent into a one-time checkbox or treating one technical standard as a universal legal answer.
Regulatory expectations also continue to evolve. The European Health Data Space Regulation, for example, applies from 26 March 2027 with staged provisions. Shiora therefore treats jurisdiction, purpose, residency, consent and identity risk as deployment inputs rather than universal claims.
Reference: Regulation (EU) 2025/327, European Health Data Space.
What Shiora provides
A configurable record and governance architecture for local assessment.
-
Consent provenance
Approved disclosure begins with a defined purpose and is designed to retain the consent, duration and revocation history.
-
Interoperability
HL7 FHIR R4 supports consented exchange where participating systems, resources and local workflows are compatible.
-
Governed cohorts
Controlled analysis, data minimisation and context-appropriate de-identification can be configured around the approved use and local legal basis.
How it works
Policy, architecture and use are assessed together.
Define the public purpose
Specify the population objective, accountable authority, permitted use, legal basis and measurable public value.
Map the jurisdiction
Assess consent, residency, cross-border transfer, retention, identity and sector-specific requirements.
Assess infrastructure
Review participating systems, supported HL7 FHIR R4 resources, identity services and local operational workflows.
Configure governed access
Apply purpose, scope, duration, minimisation, cohort and output controls appropriate to each approved use.
Retain public accountability
Consent provenance, access history, control decisions and relevant limitations remain available for authorised oversight.
Institutional boundaries
What authorised institutions can inspect. What remains protected.
Inspectable governance
Approved purpose, consent provenance, access conditions, interoperable resources, control decisions and aggregate outputs within the authorised use.
Protected by design
Open-ended record access, unrelated information, unapproved secondary use and identity disclosure beyond the legal and governance basis.
Requirements and engagement
Local assessment comes before deployment.
A government engagement begins with the responsible authority, public-health objective, jurisdictional analysis, participating systems, data-residency requirements, security review and accountability model. Clinical, technical, privacy and community stakeholders should be represented from the beginning.
A first engagement can focus on architecture and governance discovery or a tightly bounded use case. Scope, timeline and commercial terms depend on the jurisdiction, infrastructure and approvals. Compatibility with a named national system requires technical and institutional assessment.
The difference
Jurisdictional governance remains explicit.
Regulatory alignment, data residency, interoperability and identity-risk controls require deployment-specific assessment rather than a universal compliance claim.
Government FAQ
Questions for policy, clinical and digital-health leaders.
A jurisdiction-specific answer is stronger than a universal compliance claim.
Does Shiora claim universal regulatory compliance?
No. Legal, regulatory, clinical and technical requirements are assessed for each jurisdiction and approved use.
Can consent decisions be audited?
The architecture is designed to retain purpose, scope, duration and consent provenance so authorised oversight can inspect the applicable history.
Which interoperability standard is supported?
HL7 FHIR R4 supports exchange where participating systems, resources, identity services and local workflows are compatible.
How is data residency handled?
Residency and cross-border requirements are deployment inputs. The applicable architecture must be assessed and documented for the jurisdiction.
Can public-health teams access individual records?
Access depends on the legal basis and approved use. Population analysis should not imply open-ended access to personal longitudinal records.
How are secondary uses controlled?
Each use requires a defined purpose, data scope, duration and governance basis. Unrelated use is outside that approval.
Can Shiora replace a national health-information exchange?
No such replacement is implied. Shiora is assessed as a longitudinal record and governance layer within the local infrastructure.
How are small population groups protected?
Controls can include minimisation, de-identification, cohort thresholds, access restrictions and output review appropriate to the approved use.
How does a government engagement begin?
Begin with the public objective, accountable authority, jurisdictional requirements, systems landscape and one bounded use case.
Can the model support national platforms?
Potential compatibility must be established through technical, legal and institutional assessment. A standards claim alone is not a deployment commitment.
Next step